Showing results (51-60 of 163) with videos related to
Sort By:
Pageof 17
Pharmaceutics|March 6, 2020
PGE2 Is Crucial for the Generation of FAST Whole- Tumor-Antigens Loaded Dendritic Cells Suitable for Immunotherapy in GlioblastomaSara Nava, Daniela Lisini, Simona Frigerio, et al.The Journal of Gene Medicine|January 4, 2006
Brain engraftment and therapeutic potential of stem/progenitor cells derived from mouse skinPatrizia Tunici, Jeff W M Bulte, Maria Grazia Bruzzone, et al.European Journal of Neurology|May 28, 2026
Bevacizumab for Radiation-Induced (Radiculo)plexopathyAlberto Picca, Timothée Lenglet, Christophe Vandendries, et al.Neurobiology of Disease|October 4, 2005
The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activationSerena Pellegatta, Patrizia Tunici, Pietro Luigi Poliani, et al.Cancer|March 29, 2002
Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donorsFernanda Martini, Lorena Lazzarin, Laura Iaccheri, et al.Journal of Photochemistry and Photobiology. B, Biology|September 3, 2016
Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatmentAdrian Schimanski, Lara Ebbert, Michael C Sabel, et al.Journal of Clinical Medicine|November 21, 2019
Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment Against GlioblastomaValeria Cuccarini, Domenico Aquino, Andrea Gioppo, et al.Stem Cell Reports|September 21, 2013
DNA damage in mammalian neural stem cells leads to astrocytic differentiation mediated by BMP2 signaling through JAK-STATLeonid Schneider, Serena Pellegatta, Rebecca Favaro, et al.Molecular Genetics & Genomic Medicine|January 8, 2016
126 novel mutations in Italian patients with neurofibromatosis type 1Donatella Bianchessi, Sara Morosini, Veronica Saletti, et al.Journal of Neuro-Oncology|April 6, 2012
FABP4 is a candidate marker of cerebellar liponeurocytomasElena Anghileri, Marica Eoli, Rosina Paterra, et al.Pageof 17